Previous close | 46.37 |
Open | 45.90 |
Bid | 45.15 x 200 |
Ask | 45.22 x 200 |
Day's range | 44.76 - 46.51 |
52-week range | 42.08 - 77.32 |
Volume | |
Avg. volume | 1,029,680 |
Market cap | 8.232B |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Discover how Legend Biotech's robust Q1 performance and strategic initiatives are setting the stage for sustained growth.
Q1 2024 Legend Biotech Corp Earnings Call
Legend Biotech (LEGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.